MJA
MJA

Conflict of interest guidelines for clinical guidelines

Peter J McLaren
Med J Aust 2012; 196 (2): . || doi: 10.5694/mja11.11442
Published online: 6 February 2012

To the Editor: I am disappointed by Williams and colleagues’ blinkered view on “conflict of interest”.1 Their focus is solely on that of influence by profit-making medical supplies companies, often loosely referred to as “big pharma”.

Online responses are no longer available. Please refer to our instructions for authors page for more information.